{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:21:26Z","timestamp":1792002086233,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Hospitals Authority Clinical medicine Development of special funding support","award":["No.XMLX 202127"],"award-info":[{"award-number":["No.XMLX 202127"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["No.2017ZX10201201-001-006"],"award-info":[{"award-number":["No.2017ZX10201201-001-006"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2017ZX10201201-002-006\uff0c"],"award-info":[{"award-number":["2017ZX10201201-002-006\uff0c"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["No.2018ZX10715-005-003-005"],"award-info":[{"award-number":["No.2018ZX10715-005-003-005"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015850","name":"Digestive Medical Coordinated Development Center of Beijing Hospitals Authority","doi-asserted-by":"publisher","award":["No.XXZ0302"],"award-info":[{"award-number":["No.XXZ0302"]}],"id":[{"id":"10.13039\/501100015850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015850","name":"Digestive Medical Coordinated Development Center of Beijing Hospitals Authority","doi-asserted-by":"publisher","award":["No.XXT28"],"award-info":[{"award-number":["No.XXT28"]}],"id":[{"id":"10.13039\/501100015850","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Public Health Project for Capital Health Development","award":["No. 2022-1-2172"],"award-info":[{"award-number":["No. 2022-1-2172"]}]},{"name":"Project supported by Beijing science and technology commission","award":["No.Z211100002921059"],"award-info":[{"award-number":["No.Z211100002921059"]}]},{"name":"High-level Public Health Technical Personnel Training Program of Beijing Municipal Health Commission","award":["No.2022-3-050"],"award-info":[{"award-number":["No.2022-3-050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12072-022-10412-w","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T19:03:26Z","timestamp":1663268606000},"page":"42-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-5473","authenticated-orcid":false,"given":"Minghui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-8205","authenticated-orcid":false,"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-7037","authenticated-orcid":false,"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"10412_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13690-021-00686-1","volume":"79","author":"HM Kafeero","year":"2021","unstructured":"Kafeero HM, Ndagire D, Ocama P, Kudamba A, Walusansa A, Sendagire H. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Arch Public Health. 2021;79:167","journal-title":"Arch Public Health"},{"key":"10412_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","volume":"37","author":"World Health O","year":"2019","unstructured":"World Health O. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2019;37:223\u2013225","journal-title":"Vaccine"},{"key":"10412_CR3","unstructured":"Akoury T, Whetstone DR: Splenic Rupture. In: StatPearls. Treasure Island (FL), 2022."},{"key":"10412_CR4","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/hep.32333","volume":"75","author":"L Sandmann","year":"2022","unstructured":"Sandmann L, Cornberg M. HCC and HBV reactivation-A preventable condition not to be missed. Hepatology. 2022;75:1075\u20131077","journal-title":"Hepatology"},{"key":"10412_CR5","first-page":"769","volume":"9","author":"G Wang","year":"2021","unstructured":"Wang G, Duan Z. Guidelines for prevention and treatment of chronic hepatitis B. J Clin Transl Hepatol. 2021;9:769\u2013791","journal-title":"J Clin Transl Hepatol"},{"key":"10412_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijid.2017.09.003","volume":"65","author":"M Wang","year":"2017","unstructured":"Wang M, Wang Y, Feng X, Wang R, Wang Y, Zeng H, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese National Cancer Center. Int J Infect Dis. 2017;65:15\u201321","journal-title":"Int J Infect Dis"},{"key":"10412_CR7","doi-asserted-by":"crossref","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 Edition). Liver Cancer 2020;9:682\u2013720.","DOI":"10.1159\/000509424"},{"key":"10412_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560\u20131599","journal-title":"Hepatology"},{"key":"10412_CR9","doi-asserted-by":"crossref","unstructured":"Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in prevention, diagnosis, and therapy. Clin Microbiol Rev 2020;33.","DOI":"10.1128\/CMR.00046-19"},{"key":"10412_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4292\/wjgpt.v12.i4.56","volume":"12","author":"NJ Shah","year":"2021","unstructured":"Shah NJ, Aloysius MM, Sharma NR, Pallav K. Advances in treatment and prevention of hepatitis B. World J Gastrointest Pharmacol Ther. 2021;12:56\u201378","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10412_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/liv.13594","volume":"38","author":"T Kushner","year":"2018","unstructured":"Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver Int. 2018;38:813\u2013820","journal-title":"Liver Int"},{"key":"10412_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MCG.0000000000000822","volume":"52","author":"CY Chang","year":"2018","unstructured":"Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau DT, et al. Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B. J Clin Gastroenterol. 2018;52:255\u2013261","journal-title":"J Clin Gastroenterol"},{"key":"10412_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep4.1460","volume":"4","author":"SS Joshi","year":"2020","unstructured":"Joshi SS, Coffin CS. Hepatitis B and pregnancy: virologic and immunologic characteristics. Hepatol Commun. 2020;4:157\u2013171","journal-title":"Hepatol Commun"},{"key":"10412_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41395-018-0010-2","volume":"113","author":"W Yi","year":"2018","unstructured":"Yi W, Pan CQ, Li MH, Wan G, Lv YW, Liu M, et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. Am J Gastroenterol. 2018;113:686\u2013693","journal-title":"Am J Gastroenterol"},{"key":"10412_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jgh.13436","volume":"32","author":"J Liu","year":"2017","unstructured":"Liu J, Wang J, Jin D, Qi C, Yan T, Cao F, et al. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus. J Gastroenterol Hepatol. 2017;32:177\u2013183","journal-title":"J Gastroenterol Hepatol"},{"key":"10412_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/apt.12726","volume":"39","author":"V Nguyen","year":"2014","unstructured":"Nguyen V, Tan PK, Greenup AJ, Glass A, Davison S, Samarasinghe D, et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment Pharmacol Ther. 2014;39:1225\u20131234","journal-title":"Aliment Pharmacol Ther"},{"key":"10412_CR17","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374:2324\u20132334","journal-title":"N Engl J Med"},{"key":"10412_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1708131","volume":"378","author":"G Jourdain","year":"2018","unstructured":"Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med. 2018;378:911\u2013923","journal-title":"N Engl J Med"},{"key":"10412_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/ajg.2016.296","volume":"111","author":"CY Chang","year":"2016","unstructured":"Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, et al. Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B. Am J Gastroenterol. 2016;111:1410\u20131415","journal-title":"Am J Gastroenterol"},{"issue":"27","key":"10412_CR20","first-page":"938","volume":"2019","author":"Chinese Society of Infectious Diseases CMA, Chinese Society of Hepatology CMA. The guidelines of prevention and treatment for chronic hepatitis B","year":"2019","unstructured":"Chinese Society of Infectious Diseases CMA, Chinese Society of Hepatology CMA. The guidelines of prevention and treatment for chronic hepatitis B. version). Zhonghua Gan Zang Bing Za Zhi. 2019;2019(27):938\u2013961","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10412_CR21","doi-asserted-by":"crossref","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH, American Association for the Study of Liver D. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261\u2013283.","DOI":"10.1002\/hep.28156"},{"key":"10412_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12072-008-9063-4","volume":"2","author":"HH Tan","year":"2008","unstructured":"Tan HH, Lui HF, Chow WC. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int. 2008;2:370\u2013375","journal-title":"Hepatol Int"},{"key":"10412_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.796901","volume":"8","author":"R Chen","year":"2021","unstructured":"Chen R, Zou J, Long L, Huang H, Zhang M, Fan X, et al. Safety and efficacy of tenofovir alafenamide fumarate in early-middle pregnancy for mothers with chronic hepatitis B. Front Med (Lausanne). 2021;8: 796901","journal-title":"Front Med (Lausanne)"},{"key":"10412_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1\u201398","journal-title":"Hepatol Int"},{"issue":"67","key":"10412_CR25","first-page":"370","volume":"2017","author":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;2017(67):370\u2013398","journal-title":"J Hepatol"},{"key":"10412_CR26","first-page":"881","volume":"24","author":"H Zhuang","year":"2016","unstructured":"Zhuang H. Prevention of mother-to-child transmission of hepatitis B virus. Zhonghua Gan Zang Bing Za Zhi. 2016;24:881\u2013884","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10412_CR27","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2017.10.032","volume":"35","author":"Y Lu","year":"2017","unstructured":"Lu Y, Zhu FC, Liu JX, Zhai XJ, Chang ZJ, Yan L, et al. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: a large prospective cohort study in China. Vaccine. 2017;35:6627\u20136633","journal-title":"Vaccine"},{"key":"10412_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.dld.2018.11.003","volume":"51","author":"J Liu","year":"2019","unstructured":"Liu J, Xu B, Chen T, Chen J, Feng J, Xu C, et al. Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig Liver Dis. 2019;51:864\u2013869","journal-title":"Dig Liver Dis"},{"key":"10412_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cgh.2017.07.013","volume":"16","author":"KW Cheung","year":"2018","unstructured":"Cheung KW, Seto MTY, Kan ASY, Wong D, Kou KO, So PL, et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin Gastroenterol Hepatol. 2018;16:144\u2013145","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10412_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","volume":"60","author":"W Yi","year":"2014","unstructured":"Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2014;60:523\u2013529","journal-title":"J Hepatol"},{"key":"10412_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","volume":"5","author":"J Hou","year":"2017","unstructured":"Hou J, Wang G, Wang F, Cheng J, Ren H, Zhuang H, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 Update). J Clin Transl Hepatol. 2017;5:297\u2013318","journal-title":"J Clin Transl Hepatol"},{"key":"10412_CR32","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359:2442\u20132455","journal-title":"N Engl J Med"},{"key":"10412_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2169\/internalmedicine.3504-19","volume":"59","author":"M Suoh","year":"2020","unstructured":"Suoh M, Tamori A, Amano-Teranishi Y, Nakai T, Enomoto M, Kawasaki Y, et al. The administration of tenofovir disoproxil fumarate for pregnant Japanese women with chronic hepatitis B. Intern Med. 2020;59:205\u2013210","journal-title":"Intern Med"},{"key":"10412_CR34","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","volume":"61","author":"ML Chang","year":"2014","unstructured":"Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014;61:1407\u20131417","journal-title":"J Hepatol"},{"key":"10412_CR35","doi-asserted-by":"crossref","unstructured":"Sirilert S, Tongsong T. Hepatitis B virus infection in pregnancy: immunological response, natural course and pregnancy outcomes. J Clin Med 2021;10.","DOI":"10.3390\/jcm10132926"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10412-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T17:45:14Z","timestamp":1675359914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10412-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10412"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10412-w","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Minghui Li, Fangfang Sun,  Xiaoyue Bi,  Yanjie Lin,  Liu Yang, Tingting Jiang,  Wen Deng,  Yao Lu, Lu Zhang, Wei Yi and Yao Xie have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Beijing Ditan Hospital Affiliated to Capital University of Medical Sciences (Jing Di Lun Ke Zi 2017 No. 004-02), and was registered with Clinical Trials (NCT03214302).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"These patients were fully informed of the risks and signed informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}